Variational AI is redefining the unit economics of drug discovery through the power of generative AI. The founding machine learning (ML) team comes from leading AI research labs at Google, Microsoft, ...

ATR-Targeted Molecules Designed for CNS Penetration Set the Stage for Next-Generation TreatmentsVANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V ...

VANCOUVER, British Columbia, February 20, 2025--Compute efficient generative AI foundation model for small molecule drug discovery start-up announces funding from leading AI and biotech investors.

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its ...

New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies VANCOUVER, British Columbia, February 20, 2025--(BUSINESS WIRE)--Variational AI, the company ...